PREEMIE: Study for Treatment of PDA in Premature Infants

Running, not enrolling · Not applicable

Conditions studied: Patent Ductus Arteriosus (PDA)

In brief

This multicenter, single arm, prospective, non-randomized study is designed to evaluate the safety and effectiveness of The Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in pre-mature infants over a period of 6 months.

Key facts

Study ID
NCT06587282
Run by
Merit Medical Systems, Inc.
People needed
55
Starts
2025-03-06
Expected to finish
2029-03-01
Last updated by the study team
2026-05-15

Who can join

Age: 0 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.